Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
FDA Clears ViGeneron’s VG801 for Stargardt Disease
The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for VG801, ViGeneron’s novel gene therapy candidate designed to treat Stargardt disease and other retinal dystrophies caused by mutations in the ABCA4 gene. This marks…
2023 Recap: Top 15 Research in Ophthalmology
2024 Recap is here! Click to review:Top 10 Breakthroughs in Ophthalmology Research In the fast-evolving landscape of ophthalmology research, 2023 has proven to be a pivotal year marked by groundbreaking discoveries and innovation. From revolutionary cell replacement therapies to novel…
Tenpoint and Visus Merge to Advance Eye Care
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respective ophthalmic therapeutic assets to form a unified entity focused on addressing ocular conditions associated with aging, including presbyopia, cataracts, and geographic atrophy. Key Therapeutics in the Combined…
VSY Biotechnology Appoints Dr. Christian Bach MD
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has announced the appointment of Dr. Christian Bach as the new Managing Director, effective November 1, 2024. Extensive Experience in Medical Devices Dr. Bach brings over 25 years of…
VisiRose Unveils Non-Invasive Therapy for Keratitis
VisiRose, a newly established company formed in collaboration with Provectus Biopharmaceuticals and the Bascom Palmer Eye Institute (BPEI) at the University of Miami Miller School of Medicine, is advancing the development of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This…
Nona Biosciences, Kodiak Partner on Ophthalmic Antibodies
Nona Biosciences has announced a strategic partnership with Kodiak Sciences Inc. to advance the development of innovative multi-target antibodies for treating ophthalmic diseases. This collaboration leverages Nona’s proprietary Harbour Mice platform, a cutting-edge technology designed to generate fully human antibodies,…
ViaLase, Moran Eye Center Collaborate on Glaucoma
ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. This collaboration aims to accelerate glaucoma research by utilizing Moran’s state-of-the-art…
First Inverted Meniscus Optics IOLs by Voptica
*This exclusive article is sponsored by Voptica. The opinions expressed in this article are the sponsor’s own. Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at…
ESCRS 2024 Exclusive Insights: iNovation Day in Focus
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for an innovative event with its iNovation® Day in Barcelona, Spain, on Friday 6 September 2024 at the Fira Barcelona Gran Via. Scheduled to be held prior to…
OSA 2024 Winners Highlight Innovations in Ophthalmology
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, handed the prestigious Ophthalmology Star Awards 2024 (OSA) to its owners during the Satellite Symposium at the ESCRS 2024 Congress in Barcelona. The awards, which were personally presented to…